Disclaimer: This is a user generated content submitted by a member of the WriteUpCafe Community. The views and writings here reflect that of the author and not of WriteUpCafe. If you have any complaints regarding this post kindly report it to us.

Benefits offered by microbial biomanufacturing, such as low production costs and faster development timelines, have led many innovators to adopt these platforms for next generation biologics, offering lucrative opportunities for CMOs / CDMOs

Roots Analysis is pleased to announce the publication of its recent study, titled, “Microbial Contract Biomanufacturing Market, 2020-2030.”

The report features an extensive study of the current market landscape and future opportunities associated with the microbial contract biomanufacturing market. It features a detailed analysis of key drivers and trends related to this evolving domain. In addition to other elements, the study includes:

A detailed review of the current landscape of companies offering contract manufacturing services.

Elaborate profiles of key players that specialize in offering services for contract biomanufacturing.

A competitiveness analysis, highlighting key players engaged in microbial based contract manufacturing, featuring insightful pictorial summaries and representations.

An analysis of the partnerships and expansions that have been established in this domain, in the recent past.

A competitiveness analysis, highlighting key players engaged in microbial based contract manufacturing, featuring insightful pictorial summaries and representations.

A detailed proprietary 2×2 representation to assess the current market scenario

An analysis of the initiatives of big biopharma players engaged in this domain.

  • A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

Type of Product

API

FDF

Type of Biologic

  • Proteins
  • Enzymes
  • Growth Hormones
  • Antibody based Drugs
  • Others (plasmid DNA, probiotics, microbiome-based biologics)
  • Type of Microbial Expression System
  • Bacteria
  • Yeast
  • Others (Algae and fungi)

Scale of Operation

Commercial

Preclinical / Clinical

Type of End User

Small Companies

Mid-sized Companies

Large / Very Large Companies

Key Geographical Regions

North America

Europe

Asia Pacific

Middle East and North Africa

Latin America

Transcripts of interviews held with the following senior level representatives of stakeholder companies

Key companies covered in the report

  • AGC Biologics
  • Aldevron
  • BioVectra
  • EirGenix
  • Etinpro
  • Eurogentec
  • Northway Biotechpharma
  • Ology Bioservices
  • Porton Biopharma
  • Stelis Biopharma

For additional details, please visit

https://www.rootsanalysis.com/reports/microbial-contract-biomanufacturing-market.html or email sales@rootsanalysis.com

You may also be interested in the following titles:

Contact:

Gaurav Chaudhary

+1 (415) 800 3415

+44 (122) 391 1091

Gaurav.Chaudhary@rootsanalysis.com

Login

Welcome to WriteUpCafe Community

Join our community to engage with fellow bloggers and increase the visibility of your blog.
Join WriteUpCafe